Nutex Health, Inc. Cash Flow Statement
NUTX / Industrials|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Nutex Health, Inc. generated $248M in operating cash flow and $246M in free cash flow in FY2025. Free cash flow margin was 28.1% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $70.8M | $52.1M | -$45.8M | -$424.8M | $132.6M | $106.0M | -$7.1M | -$950.1K | $582.1K | -$7.4M | $83.8K | -$684.3K | $250.5K | -$1.6M | -$383.4K |
| Depreciation & Amortization | $20.5M | $19.0M | $17.6M | $13.1M | $7.7M | $5.9M | $156.1K | $2.7K | - | $473 | - | $63.3K | $40.3K | - | - |
| Operating Cash Flow | $248.1M | $23.2M | $1.3M | $50.6M | $173.4M | $86.7M | -$4.0M | -$480.0K | -$714.6K | -$274.2K | $44.9K | $159.2K | -$183.2K | -$518.7K | -$659.1K |
| Capital Expenditures | $2.5M | $2.3M | $9.5M | $14.6M | $36.9M | $61.2M | $84.0K | $0 | - | - | -$1.8K | -$2.0K | - | -$8.1K | -$19.4K |
| Free Cash Flow | $245.6M | $20.8M | -$8.2M | $36.0M | $136.5M | $25.5M | -$4.1M | -$480.0K | - | - | $46.7K | $161.2K | - | -$510.6K | -$639.7K |
| Share Buybacks | $5.0M | $0 | $0 | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | 28.1% | 4.3% | -3.3% | 16.4% | 41.2% | 9.3% | -301.9% | -35.1% | - | - | 9.8% | 15.1% | - | -32.0% | -35.9% |